The use of ELM to monitor the success of antiscabietic treatment. Epiluminescence light microscopy.
Haas
N
N
Sterry
W
W
D000279:Administration, Cutaneous; D000284:Administration, Oral; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000818:Animals; D001565:Benzoates / Q000008:administration & dosage / Q000627:therapeutic use; D002648:Child; D003952:Diagnostic Imaging; D005260:Female; D001556:Hexachlorocyclohexane / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D007223:Infant; D007306:Insecticides / Q000008:administration & dosage / Q000627:therapeutic use*; D007559:Ivermectin / Q000008:administration & dosage / Q000627:therapeutic use*; D008297:Male; D008853:Microscopy; D008875:Middle Aged; D008925:Mites / Q000033:anatomy & histology; D012532:Scabies / Q000188:drug therapy* / Q000473:pathology; D016896:Treatment Outcome
D001565:Benzoates; D007306:Insecticides; D001556:Hexachlorocyclohexane; D007559:Ivermectin; C006723:benzyl benzoate